Concepedia

Takashi Nomizo

TN

15

Publications

472

Citations

12

H-Index

2016

Active since

Affiliations

Kyoto University(Current)

Kyoto University Hospital

Takashi Nomizo is an author at Kyoto University specializing in lung cancer, cancer therapeutics, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2023

15

Publications

15

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Takashi Nomizo, Hiroaki Ozasa, Takahiro Tsuji et al. · Scientific Reports · 2017 · 117 citations · Full text

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Nature Communications · 2020 · 80 citations · Full text

Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model

Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Molecular Cancer Research · 2018 · 47 citations · Full text

MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression

Yuto Yasuda, Hiroaki Ozasa, Young Hak Kim et al. · Cell Death and Disease · 2020 · 47 citations · Full text

Nivolumab in non-small-cell lung cancer with EGFR mutation

Hironori Yoshida, Y.H. Kim, Hiroaki Ozasa et al. · Annals of Oncology · 2017 · 35 citations · Full text

Rows per page

1–5 of 15